Octagon Capital Advisors LP Kura Oncology, Inc. Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding KURA
# of Institutions
173Shares Held
80.4MCall Options Held
914KPut Options Held
120K-
Suvretta Capital Management, LLC New York, NY7.07MShares$146 Million6.46% of portfolio
-
Black Rock Inc. New York, NY6.9MShares$142 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$120 Million3.53% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$111 Million2.38% of portfolio
-
Bvf Inc San Francisco, CA4.79MShares$98.5 Million3.06% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.38B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...